ID: ALA375035

Max Phase: Preclinical

Molecular Formula: C11H13BrN2O6

Molecular Weight: 349.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1/C=C/Br

Standard InChI:  InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8-,10-/m1/s1

Standard InChI Key:  GCQYYIHYQMVWLT-YPLKXGEDSA-N

Associated Targets(Human)

CCRF-HSB-2 188 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MRC5 9203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mo 135 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

E6SM 1586 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

M21 1715 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEp-2 3859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human alphaherpesvirus 1 11089 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human alphaherpesvirus 2 4932 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human alphaherpesvirus 3 4092 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NIH3T3 5395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vero 26788 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BSC-1 357 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

E1 SM 3 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 349.14Molecular Weight (Monoisotopic): 347.9957AlogP: -1.49#Rotatable Bonds: 3
Polar Surface Area: 124.78Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.74CX Basic pKa: CX LogP: -1.40CX LogD: -1.40
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.53Np Likeness Score: 1.30

References

1. De Clercq E, Desgranges C, Herdewijn P, Sim IS, Jones AS, McLean MJ, Walker RT..  (1986)  Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.,  29  (2): [PMID:3005566] [10.1021/jm00152a008]
2. Onishi T, Mukai C, Nakagawa R, Sekiyama T, Aoki M, Suzuki K, Nakazawa H, Ono N, Ohmura Y, Iwayama S, Okunishi M, Tsuji T..  (2000)  Synthesis and antiviral activity of novel anti-VZV 5-substituted uracil nucleosides with a cyclopropane sugar moiety.,  43  (2): [PMID:10649983] [10.1021/jm9904194]
3. Reefschläger J, Pein CD, Cech D..  (1988)  Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues.,  31  (2): [PMID:2828623] [10.1021/jm00397a022]
4. Kitano K, Machida H, Miura S, Ohrui H..  (1999)  Synthesis of novel 4'-C-methyl-pyrimidine nucleosides and their biological activities.,  (6): [PMID:10206544] [10.1016/s0960-894x(99)00090-6]

Source